Jpmorgan Chase & CO Connect Biopharma Holdings LTD Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 121 shares of CNTB stock, worth $216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121
Previous 121
-0.0%
Holding current value
$216
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
3.95MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.06MShares$3.69 Million2.4% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$1.86 Million0.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$914,1540.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny240KShares$429,4210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA28KShares$50,0500.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $98.5M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...